Profil
Marcin Mankowski was the founder of Transcrip Ltd., founded in 2008, and held the title of Chief Executive Officer from 2021 to 2023.
Current jobs include Director & Deputy Managing Partner at TranScrip Partners LLP and Chief Medical Officer & Head-Scientific Affairs at Synairgen Plc starting in 2023.
Education history includes an undergraduate degree from Warszawski Uniwersytet Medyczny.
Postes actifs de Marcin Mankowski
| Sociétés | Poste | Début |
|---|---|---|
| SYNAIRGEN PLC | Directeur Technique/Scientifique/R&D | 03/10/2023 |
TranScrip Partners LLP
TranScrip Partners LLP Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | - |
Anciens postes connus de Marcin Mankowski
| Sociétés | Poste | Fin |
|---|---|---|
Transcrip Ltd.
Transcrip Ltd. Pharmaceuticals: GenericHealth Technology Develops drugs for medicines | Fondateur | 02/01/2023 |
Formation de Marcin Mankowski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Synairgen Plc
Synairgen Plc Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for respiratory disorders | Health Technology |
Warszawski Uniwersytet Medyczny
Warszawski Uniwersytet Medyczny Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TranScrip Partners LLP
TranScrip Partners LLP Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Transcrip Ltd.
Transcrip Ltd. Pharmaceuticals: GenericHealth Technology Develops drugs for medicines | Health Technology |
















